12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, health care stocks showed significant movement. Adial Pharmaceuticals (ADIL) and NKGen Biotech (NKGN) led the gainers with over 30% increases in their stock prices, while Vaxxinity (VAXX) and Hepion Pharmaceuticals (HEPA) were among the top losers, with VAXX stock dropping over 60%. The movements were attributed to various factors, including recent earnings reports for some companies.
April 22, 2024 | 12:07 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Adial Pharmaceuticals stock rose 34.2% to $2.59, with a market cap of $10.5 million.
The significant pre-market increase in ADIL's stock price could attract more investor interest, potentially leading to short-term price volatility.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
NKGen Biotech shares surged 32.0% to $1.46, following their Q4 earnings report 4 days ago.
NKGN's recent earnings report likely contributed to the positive investor sentiment, driving up its stock price in the short term.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Hepion Pharmaceuticals stock declined by 37.82% to $1.25, following their Q4 earnings report 4 days ago.
The negative reaction to HEPA's recent Q4 earnings report suggests concerns among investors, potentially leading to further short-term declines.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
Vaxxinity stock declined by 61.3% to $0.18, with a market cap of $23.3 million.
The drastic drop in VAXX's stock price could indicate negative investor sentiment or reactions to recent company developments, likely leading to further short-term volatility.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 90